MedPath

Effect of Remifentanil on Postoperative Vomiting in Pediatric Strabismus Surgery

Not Applicable
Completed
Conditions
Strabismus
Interventions
Registration Number
NCT02455401
Lead Sponsor
Inje University
Brief Summary

The purpose of this study is to compare the effect of remifentanil on postoperative vomiting in children undergoing strabismus surgery during sevoflurane anesthesia.

Detailed Description

Children undergoing strabismus surgery frequently experience postoperative vomiting (POV) that results in dehydration, aspiration pneumonia, bleeding, delayed hospital discharge, as well as decreased parental satisfaction and an unpleasant experience for the pediatric patients. Although administration of perioperative opioids increases POV incidence, remifentanil has less affect the incidence of POV than other opioids such as fentanyl. However, there are few study that evaluate the effects of remifentanil on the incidence of POV. Therefore, the investigators will conducted the study that the effects of remifentanil on the incidence of POV in children undergoing strabismus surgery during sevoflurane anesthesia. One hundred five children from 3 to 6 yr of age, ASA physical status 1 or 2 were assigned randomly selected to one of three groups: high dose remifentanil group (bolus 1.0 mcg/kg; infusion 0.1 mcg/kg/min), low remifentanil group (bolus 0.5 mcg/kg; infusion 0.1 mcg/kg/min), or no remifentanil group (no remifentanil administration). Primary endpoint, the incidence of POV for 24 hours postoperatively, will be compared between three study groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • children undergoing elective strabismus surgery under sevoflurane anesthesia
Exclusion Criteria
  • children who experienced postoperative retching or vomiting
  • children who have taken anti-emetic medications within 24 hours before surgery
  • children who experienced motion sickness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
No remifentanil groupNo remifentanilIntervention: no remifenatnil will be administrated
high dose remifentanil groupHigh dose remifentanilIntervention: high dose remifentanil will be administrated.
low dose remifentanil groupLow dose remifentanilIntervention: low dose remifentanil will be administrated
Primary Outcome Measures
NameTimeMethod
incidence of postoperative vomiting in PACU and surgical wardfrom extubation to 24 hours

Vomiting is expulsion of gastric contents. Incidence of vomiting will be compared between the groups.

Secondary Outcome Measures
NameTimeMethod
postoperative pain in PACU and surgical wardfrom extubation to 24 hours

Postoperative pain will be assessed using Faces Pain Rating Scale.

postoperative emergence agitationfrom extubation to 24 hours

Postoperative emergence agitation will be assessed using Pediatric Anesthesia Emergence Delirium.

Trial Locations

Locations (1)

Haeundae paik hospital, inje university

🇰🇷

Busan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath